Liquidia Corporation (LQDA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
419 Davis Drive
Morrisville, NC 27560
United States of America (the)
Phone
919 328 4400
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
216
First IPO Date
July 26, 2018
| Name | Title | Pay | Year Born |
| Roger A. Jeffs | Chief Executive Officer & Director | 2.12M | 1962 |
| Scott Moomaw | Chief Commercial Officer | 980,961 | 1971 |
| Rajeev Saggar | Chief Medical Officer | 1.17M | 1975 |
| Russell Schundler | General Counsel & Corporate Secretary | 1.17M | 1976 |
| Michael Kaseta | Chief Operating Officer & Chief Financial Officer | 1.41M | 1976 |
| Dana Boyle | Chief Accounting Officer | 0 | 1985 |
| Matt Snow | Senior Vice President of Sales | 0 | N/A |
| Michael Post | Senior Vice President of Marketing | 0 | N/A |
| Sarah Krepp SPHR | Chief Human Resources Officer | 0 | 1982 |
| Christian Perez Font | Senior Vice President, Chief Compliance Officer & Associate General Counsel | 0 | N/A |
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.